Crossmark Global Holdings, Inc. Bio Rad Laboratories, Inc. Transaction History
Crossmark Global Holdings, Inc.
- $6.02 Billion
- Q2 2025
A detailed history of Crossmark Global Holdings, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 1,003 shares of BIO stock, worth $322,865. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,003
Previous 966
3.83%
Holding current value
$322,865
Previous $235,000
2.98%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding BIO
# of Institutions
426Shares Held
19.2MCall Options Held
10.7KPut Options Held
35.5K-
First Eagle Investment Management, LLC2.52MShares$810 Million1.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$594 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$499 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1MShares$322 Million0.06% of portfolio
-
Veritas Asset Management LLP863KShares$278 Million2.27% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $7.93B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...